(Q42818112)
Statements
Antiadipogenic effects of the mineralocorticoid receptor antagonist drospirenone: potential implications for the treatment of metabolic syndrome (English)
Antonella Antelmi
Gérard Chetrite
Adeline Muscat
Caterina Mammi
Andrea Fabbri
17 November 2010